Phosphoenolpyruvate, a glycolytic intermediate, as a cytoprotectant and antioxidant in ex‐vivo cold‐preserved mouse liver: a potential application for organ preservation. (16th November 2012)
- Record Type:
- Journal Article
- Title:
- Phosphoenolpyruvate, a glycolytic intermediate, as a cytoprotectant and antioxidant in ex‐vivo cold‐preserved mouse liver: a potential application for organ preservation. (16th November 2012)
- Main Title:
- Phosphoenolpyruvate, a glycolytic intermediate, as a cytoprotectant and antioxidant in ex‐vivo cold‐preserved mouse liver: a potential application for organ preservation
- Authors:
- Kondo, Yuki
Ishitsuka, Yoichi
Kadowaki, Daisuke
Fukumoto, Yusuke
Miyamoto, Yohei
Irikura, Mitsuru
Hirata, Sumio
Sato, Keizo
Maruyama, Toru
Hamasaki, Naotaka
Irie, Tetsumi - Abstract:
- <abstract abstract-type="main"> <title>Abstract</title> <sec id="jphp1602-sec-0001" sec-type="section"> <title>Objectives</title> <p>The aim of this study was to examine the effect of phosphoenolpyruvate (PEP), a glycolytic intermediate, on organ damage during cold preservation of liver.</p> </sec> <sec id="jphp1602-sec-0002" sec-type="section"> <title>Methods</title> <p>An ex‐vivo mouse liver cold‐preservation model and an in‐vitro liver injury model induced by hydrogen peroxide in HepG2 cells were leveraged.</p> </sec> <sec id="jphp1602-sec-0003" sec-type="section"> <title>Key findings</title> <p>PEP attenuated the elevation of aminotransferases and lactate dehydrogenase leakage during organ preservation, histological changes and changes in oxidative stress parameters (measured as thiobarbituric acid reactive substance and glutathione content) induced by 72 h of cold preservation of the liver. The effects were comparable with the University of Wisconsin solution, a gold standard organ preservation agent. The decrease in ATP content in liver during the cold preservation was attenuated by PEP treatment. PEP prevented the cellular injury and increases in intracellular reactive oxygen species in HepG2 cells. In addition, PEP scavenged hydroxyl radicals, but had no effect on superoxide anion as evaluated by an electron paramagnetic resonance spin‐trapping technique.</p> </sec> <sec id="jphp1602-sec-0004" sec-type="section"> <title>Conclusions</title> <p>PEP significantly<abstract abstract-type="main"> <title>Abstract</title> <sec id="jphp1602-sec-0001" sec-type="section"> <title>Objectives</title> <p>The aim of this study was to examine the effect of phosphoenolpyruvate (PEP), a glycolytic intermediate, on organ damage during cold preservation of liver.</p> </sec> <sec id="jphp1602-sec-0002" sec-type="section"> <title>Methods</title> <p>An ex‐vivo mouse liver cold‐preservation model and an in‐vitro liver injury model induced by hydrogen peroxide in HepG2 cells were leveraged.</p> </sec> <sec id="jphp1602-sec-0003" sec-type="section"> <title>Key findings</title> <p>PEP attenuated the elevation of aminotransferases and lactate dehydrogenase leakage during organ preservation, histological changes and changes in oxidative stress parameters (measured as thiobarbituric acid reactive substance and glutathione content) induced by 72 h of cold preservation of the liver. The effects were comparable with the University of Wisconsin solution, a gold standard organ preservation agent. The decrease in ATP content in liver during the cold preservation was attenuated by PEP treatment. PEP prevented the cellular injury and increases in intracellular reactive oxygen species in HepG2 cells. In addition, PEP scavenged hydroxyl radicals, but had no effect on superoxide anion as evaluated by an electron paramagnetic resonance spin‐trapping technique.</p> </sec> <sec id="jphp1602-sec-0004" sec-type="section"> <title>Conclusions</title> <p>PEP significantly attenuated the injury, oxidative stress and ATP depletion in liver during cold preservation. The antioxidative potential of PEP was confirmed by in‐vitro examination. We suggest that PEP acts as a glycolytic intermediate and antioxidant, and is particularly useful as an organ preservation agent in clinical transplantation.</p> </sec> </abstract> … (more)
- Is Part Of:
- Journal of pharmacy and pharmacology. Volume 65:Number 3(2013:Mar.)
- Journal:
- Journal of pharmacy and pharmacology
- Issue:
- Volume 65:Number 3(2013:Mar.)
- Issue Display:
- Volume 65, Issue 3 (2013)
- Year:
- 2013
- Volume:
- 65
- Issue:
- 3
- Issue Sort Value:
- 2013-0065-0003-0000
- Page Start:
- 390
- Page End:
- 401
- Publication Date:
- 2012-11-16
- Subjects:
- Pharmacy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- https://academic.oup.com/jpp ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)2042-7158 ↗
http://onlinelibrary.wiley.com/ ↗
http://www.ingentaconnect.com/content/rpsgb/jpp ↗ - DOI:
- 10.1111/j.2042-7158.2012.01602.x ↗
- Languages:
- English
- ISSNs:
- 0022-3573
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5034.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3240.xml